New anemia drug for dialysis patients enters final testing phase
Disease control
Recruiting now
This study tests a new medicine called AND017 for people with end-stage kidney disease who are on dialysis and have anemia (low red blood cells). The goal is to see if AND017 can keep hemoglobin levels stable compared to current treatments. About 300 adults will take part, and th…
Phase: PHASE3 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated May 06, 2026 16:13 UTC